Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.71	26.63	13.27	23.77	21.1	30.34
Cash & Short-Term Investments	18.71	26.63	13.27	23.77	21.1	30.34
Cash Growth	-56.55%	100.72%	-44.19%	12.67%	-30.46%	122.30%
Receivables	17.5	12.88	8.81	1.55	-	-
Inventory	2.2	1.06	2.16	0.58	-	-
Prepaid Expenses	1.42	3.08	2.58	0.77	1.03	0.8
Other Current Assets	0.97	0.47	0.04	0.06	0.25	0.28
Total Current Assets	40.79	44.12	26.86	26.73	22.39	31.42
Long-Term Deferred Charges	-	0.82	0.01	0.21	0.03	-
Total Assets	44.88	44.95	26.86	26.94	22.41	31.42
Accounts Payable	5.94	3.24	3.78	2.39	0.78	1.57
Accrued Expenses	2.23	3.43	3.75	2.22	0.88	0.78
Current Portion of Leases	-	0	0.02	-	-	-
Current Unearned Revenue	0.25	0.25	-	-	-	-
Total Current Liabilities	8.41	6.92	7.55	4.61	1.65	2.35
Long-Term Debt	19.36	19.34	30.93	24.9	4.99	-
Long-Term Unearned Revenue	24.56	24.56	0	-	-	-
Total Liabilities	52.34	50.82	38.49	29.51	6.64	2.35
Common Stock	146.17	145.61	144.31	142.59	140.8	140.73
Additional Paid-In Capital	69.13	66.96	62.07	56.8	53.21	49.23
Retained Earnings	-224	-219.68	-219.25	-203.2	-179.49	-162.14
Comprehensive Income & Other	1.24	1.24	1.24	1.24	1.24	1.24
Shareholders' Equity	-7.46	-5.87	-11.62	-2.57	15.77	29.07
Total Liabilities & Equity	44.88	44.95	26.86	26.94	22.41	31.42
Total Debt	19.36	19.34	30.95	24.9	4.99	-
Net Cash (Debt)	-0.66	7.29	-17.68	-1.13	16.11	30.34
Net Cash Growth	-	-	-	-	-46.90%	122.30%
Net Cash Per Share	-0.02	0.27	-0.67	-0.04	0.62	1.28
Filing Date Shares Outstanding	27.33	27.59	27.1	26.41	26.01	26
Total Common Shares Outstanding	27.33	27.53	27.03	26.36	26.01	26
Working Capital	32.38	37.21	19.31	22.12	20.73	29.07
Book Value Per Share	-0.27	-0.21	-0.43	-0.10	0.61	1.12
Tangible Book Value	-7.46	-5.87	-11.62	-2.57	15.77	29.07
Tangible Book Value Per Share	-0.27	-0.21	-0.43	-0.10	0.61	1.12

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q